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ABSTRACT
Introduction: Over recent years, there has been
concerted effort to ‘close the gap’ in the
disproportionately reduced life expectancy and
increased morbidity experienced by indigenous
compared to non-indigenous persons. Specific to
musculoskeletal health, some data suggest that
indigenous peoples have a higher risk of sustaining a
fracture compared to non-indigenous peoples. This
creates an imperative to identify factors that could
explain differences in fracture rates. This protocol
presents our aim to conduct a systematic review, first,
to determine whether differences in fracture rates exist
for indigenous versus non-indigenous persons and,
second, to identify any risk factors that might explain
these differences.
Methods and analysis: We will conduct a systematic
search of PubMed, OVID, MEDLINE, CINAHL and
EMBASE to identify articles that compare all-cause
fracture rates at any skeletal site between indigenous
and non-indigenous persons of any age. Eligibility of
studies will be determined by 2 independent reviewers.
Studies will be assessed for methodological quality
using a previously published process. We will conduct
a meta-analysis and use established statistical methods
to identify and control for heterogeneity where
appropriate. Should heterogeneity prevents numerical
syntheses, we will undertake a best-evidence analysis
to determine the level of evidence for differences in
fracture between indigenous and non-indigenous
persons.
Ethics and dissemination: This systematic review
will use published data; thus, ethical permissions are
not required. In addition to peer-reviewed publication,
findings will be presented at (inter)national
conferences, disseminated electronically and in print,
and will be made available to key country-specific
decision-makers with authority for indigenous health.
INTRODUCTION
According to the United Nations, there are
>370 million indigenous persons worldwide
living in ∼70 countries. By deﬁnition,
indigenous persons are the descendants of
those who originally inhabited a country or
geographical region and are spread across
the world from the Arctic to the South
Paciﬁc. Among indigenous peoples are those
of the Americas (eg, the Native Americans in
the USA, the First Nations and Métis of
Canada, the Mayas in Guatemala and the
Aymaras in Bolivia), the Inuit and Aleutians
Strengths and limitations of this study
▪ Our systematic review will fill a gap in the
evidence-base by providing a comprehensive
assessment of the existing literature to compare
fracture rates between indigenous and non-
indigenous populations worldwide. In reviewing
the literature, we will establish (1) if a difference
exists, (2) the magnitude of any differences and
(3) what risk factors for differences in fracture
rates have been identified.
▪ Study selection, data extraction and assessment
of methodology will be conducted independently
by two authors.
▪ The findings of this systematic review will inform
the evidence-base that decision-makers working
in health policy can use to enhance the targeting
of interventions to prevent fractures in indigen-
ous persons.
▪ A potential limitation of this review might be that
different countries have different definitions of
indigenous status; however, to address this, we
will include articles that align with Article 33 of
the United Nations Declaration on the Rights of
Indigenous Peoples definition of indigenous
status, where the importance of self-identification
as an indigenous person is underlined.
▪ It is possible that we may identify a paucity of
data in this area of enquiry; this may reflect sys-
temic disenfranchisement from the mainstream
research community and thus identify a research
gap, which could be considered analogous to
the postfracture ‘care gap’.
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of the north circumpolar region, the Saami of northern
Europe, the Aborigines and Torres Strait Islanders of
Australia and the Maori of New Zealand. Indigenous
persons practice unique traditions and retain social, cul-
tural, economic and political characteristics that are dis-
tinct from those of the dominant societies in which they
live.1 Indigenous peoples constitute ∼5% of the world’s
population; however, they account for ∼15% of the
world’s poor.2
Among high-income countries, four countries are
often considered comparable in terms of indigenous
well-being: Australia, the USA, New Zealand and
Canada. These four countries consistently place near
the top of the United Nations Development
Programme’s Human Development Index rankings,
yet all have minority indigenous populations with much
poorer health and social conditions than their non-
indigenous compatriots.3 Disproportionately reduced
life expectancies are observed for indigenous peoples
compared to non-indigenous peoples;3 4 in Australia,
there is a ∼10-year gap with the average life expectancy
being 59.5 years,5 6 American Native peoples and
Alaskan natives live an average of 70.8 years, New
Zealand Maoris live an average of 71.1 years, and
Canadian First Nations, Métis and Inuit peoples live an
average of 72.8 years.3 5 Although the United Nations
advocates for the right of everyone to the highest attain-
able standard of health,7 Canadian First Nations women
have lower health-related quality of life than Caucasian
women.8 Indeed, data suggest that 80% of the life
expectancy gap between indigenous and non-indigenous
persons is attributable to chronic diseases.9
It is well documented that a fragility fracture due to
osteoporosis is a strong independent risk factor for sub-
sequent fracture.10 11 Furthermore, a fracture of the hip
can reduce life expectancy12 13 and quality of life, and
places a greater demand on health infrastructure.13–15
Importantly, data from Manitoba, Canada, showed not
only an independent contribution of First Nations status
to postfracture mortality but also a larger absolute
increase in postfracture mortality for First Nations com-
pared to non-First Nations peoples.16 Excess mortality
attributable to fracture in indigenous persons has not
been investigated in other countries. Furthermore, dis-
ability related to musculoskeletal diseases is increasing
due to population growth and a shift in the population
age structure.17 Explanatory variables that may account
for the increased risk of fracture in indigenous persons
are imperative to elucidate. For instance, we know that
there is a heavy burden of chronic health conditions suf-
fered by indigenous persons,5 18 including type 2 dia-
betes.19 Thus, an improved understanding regarding
potentially modiﬁable factors can enhance attempts to
close the gap in life expectancy.
This article presents the protocol for a systematic
review, which ﬁrst aims to identify and compare all-cause
fracture rates in indigenous compared with non-
indigenous populations; this important area of enquiry
has not been addressed by a comprehensive review of
existing literature, as identiﬁed by a search of the
Cochrane Library (performed 29 February 2016).
Possible risk factors that contribute to any observed dif-
ferences in fracture rates will also be investigated, as a
secondary aim of interest. This protocol adheres to the
Preferred Reporting Items for Systematic reviews and
Meta-Analyses Protocols (PRISMA-P) guidelines.20
Objectives
This systematic review will:
1. Identify published studies that compare all-cause frac-
ture rates between indigenous and non-indigenous
populations across the entire age spectrum;
2. Evaluate the methodological quality of all eligible
studies according to a previously employed scoring
system;21 22
3. Analyse the level of evidence for all studies com-
bined, and conduct two subgroup analyses to:
A. Compare high versus low methodological quality
(above the median) to determine whether any
bias is observed;
B. Explore heterogeneity by excluding those studies
that did not account for socioeconomic variables.
METHODS
Indigenous status
Rather than employing a deﬁnition of indigenous status,
our inclusion criteria for eligible studies will align with
Article 33 of the United Nations Declaration on the Rights of
Indigenous Peoples, in which the importance of self-
identiﬁcation as an indigenous person is underlined.1 23
However, we will also include articles that determine
indigenous status by the use of country-speciﬁc identity
registration systems.
Criteria for considering studies for this review
The criteria for inclusion in this review will be: full-text
articles that are epidemiological cohort, case–control
and/or cross-sectional studies and that examine fracture
rates in indigenous populations, or indigenous versus
non-indigenous populations, inclusive of any country,
sex or age.
Grey literature and conference presentations will be
excluded. Furthermore, given that the purpose of this
review is to ascertain whether bone quality and/or frac-
ture rates differ between non-indigenous and indigen-
ous populations, randomised controlled trials (RCTs)
will be excluded. However, where possible, we will
include baseline data from RCTs that pertain to fracture
rates prior to intervention, as it is possible that the data
from cases may provide relevant cross-sectional informa-
tion, and data from the controls would be equivalent to
a cohort study. Articles that investigate indigenous and
non-indigenous persons but do not present ﬁndings sep-
arately for each group will not be eligible for inclusion.
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Search strategy and data extraction
We will perform a computer-generated search strategy
using databases for medical, health and social sciences
(PubMed, OVID, MEDLINE, CINAHL and EMBASE) to
identify relevant literature, with no limits set on the date
of publication. We will apply the following medical
subject headings (MeSH): ‘osteoporosis’ OR ‘fractures’
OR ‘bone’ AND (‘Indigenous’ OR ‘Aborigines’ OR
‘Inuit’ OR ‘Indians, Central American’ OR ‘Indians,
North American’ OR ‘Indians, South American’ OR
‘Oceanic Ancestry Group’). Key words (informed by the
United Nations Permanent Forum on Indigenous Issues1 23)
will include: aboriginal, Aleutians, American Indian,
First Nation, Lakota, Maasai, Maori, Mayas, Métis, Native
Americans, Native-born, Saami, Torres Strait Islander
and indigenous peoples. Relevant truncation will be
used for each database. Reference lists of relevant
studies that fulﬁl the eligibility criteria will be independ-
ently hand-searched by two reviewers (SLB-O and BJD).
One reviewer will perform the search strategy (SLB-O),
and two further reviewers (SEQ and BJD) will conﬁrm
the selection of articles. Where articles are written in a
language other than English, we will seek professional
assistance with interpretation for a comparison against
the selection criteria.
Assessment of methodological quality of included articles
Data extracted from included studies will be analysed
using a modiﬁed version of the methodological scoring
system of Lievense et al.21 22 We have previously
employed this methodology to determine the quality of
cohort, case–control and cross-sectional study designs in
the musculoskeletal research ﬁeld.24–26 As part of the
modiﬁcation to the Lievense et al tool, only those 15 cri-
teria that assessed ‘internal validity’ of the studies were
retained, while those 4 criteria that assessed ‘informative-
ness’ were removed. Brieﬂy, the methodology of eligible
studies will be scored using predetermined criteria as
follows: positive (1) or negative (0), with 100% repre-
senting a maximum obtainable score for each of the
study designs (ﬁgure 1). According to the scoring
system, cohort studies reﬂect the optimal study design
due to the inherent prospective qualities, followed by
case–control studies and then cross-sectional study
designs.
Two reviewers (SLB-O and SEQ) will independently
score eligible studies using the Lievense et al21 22 scoring
system. Should the scorers disagree with differences that
cannot be reconciled, a third reviewer will provide the
ﬁnal judgement in one consensus meeting (LJW). The
total score (%) for each of the studies will be calculated
Figure 1 Criteria list for the assessment of methodological quality, modified from Lievense et al.21 22
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and, subsequently, deemed as high quality if scoring
above the median of the total scores.
Presenting and reporting results
Results of this systematic review will be presented accord-
ing to the PRISMA-P reporting guidelines.20 We will
provide an adapted QUORUM diagram,27 which will
present a ﬂow chart of study selection, and reasons for
including or excluding articles, including observational
studies. A description of all relevant studies will be pre-
sented, and the following key information will be manu-
ally extracted from those articles eligible for inclusion:
author, country from where the sample was drawn
(including region/state/district where available), popu-
lation description, indigenous status, fracture ascertain-
ment and skeletal site. Results of the methodological
scoring for all articles will be presented as a percentage.
We will also provide details of the modelling procedures
employed by each of the studies to investigate asso-
ciations between indigenous status and fracture, includ-
ing the factors that were included in models (including
the exposure variable/s), the statistical results and a
summary of the authors’ ﬁndings.
We will conduct a meta-analysis and use statistical
methods to control for heterogeneity where appropriate.
We will also perform subset and/or sensitivity analyses to
further explore heterogeneity, whereby those studies
that did not account for socioeconomic variables are
excluded. Should statistical heterogeneity prevents a
numerical synthesis, we will employ a best-evidence syn-
thesis to assess the level of evidence available, whereby
the level of evidence could range from strong evidence
to no evidence (table 1).21 22 We have previously pub-
lished best-evidence syntheses regarding determinants of
fracture.24 26
Dissemination
Findings from this systematic review will be published in
a peer-reviewed scientiﬁc journal. Our results will also
be presented at national and international conferences
and will be made available to key country-speciﬁc
decision-makers with authority for indigenous health.
Ethics
Given that this systematic review will use published data,
we do not require ethical permissions. However, our
research processes will adhere to ethical and governance
standards with regards to data management, and the
presentation and discussion of our ﬁndings.
Furthermore, our protocol has been informed by indi-
genous person/s from Australia, who is also engaged in
our authorship list.
Conclusion
To the best of our knowledge, this will be the ﬁrst review
of its kind to explore the association between indigenous
status and fracture rates. Investigating whether differ-
ences exist in fracture rates between indigenous and
non-indigenous populations has broad policy and prac-
tice implications. Furthermore, these data will inform
the evidence-base to support existing and future health
campaigns and resource allocation to improve health of
indigenous peoples and reduce gaps in their life expect-
ancy related to postfracture mortality. Should a paucity
of data be identiﬁed, this will indicate a clear research
gap, and a possible disenfranchisement from main-
stream research, that will require urgent attention;
however, the authors are aware of a number of studies
that fulﬁl the eligibility criteria28–32 and, thus, will avoid
the scenario of an ‘empty’ systematic review report.
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Table 1 Criteria for ascertainment of evidence level for
best-evidence synthesis, adapted from Lievense et al21
Level of
evidence
Criteria for inclusion in
best-evidence synthesis
Strong evidence Generally consistent findings in:
Multiple high-quality cohort studies
Moderate
evidence
Generally consistent findings in:
One high-quality cohort study and
>2 high-quality case–control studies
>3 high-quality case–control studies
Limited
evidence
Generally consistent findings in:
Single cohort study
One or two case–control studies or
Multiple cross-sectional studies
Conflicting
evidence
Inconsistent findings in <75% of the
studies
No evidence No studies could be found
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